← All Sponsors
SPONSOR

Medical University of Vienna

Total Trials
17
Recruiting
17
Phases
Phase 4, Phase 2, Phase 1

Medical University of Vienna is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including PICS, PICS-F, Communication Barriers, Liver Cirrhosis.

The trial portfolio spans Phase 4, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Medical University of Vienna

How many clinical trials has Medical University of Vienna sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by Medical University of Vienna, of which 17 are actively recruiting participants. These trials cover conditions including PICS, PICS-F, Communication Barriers. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Medical University of Vienna research focus on?
Medical University of Vienna clinical trials span PICS, PICS-F, Communication Barriers, Liver Cirrhosis, COVID-19, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Medical University of Vienna clinical trial?
To participate in a Medical University of Vienna trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Medical University of Vienna trials with current recruitment status updated daily.

Clinical Trials by Medical University of Vienna

NCT07290712
Recruiting

Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region

PICS
NCT06322004
Recruiting

Video-Interpreting in Prehospital Emergency Medicine - Feasibility Study

Communication Barriers
NCT05667805 Phase 4
Recruiting

Coagulation in Cirrhosis

Liver Cirrhosis
NCT05650905
Recruiting

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

COVID-19
NCT03821467
Recruiting

Reproducibility of Dual Beam Doppler Fourier-domain Optical Coherence Tomography in Healthy Subjects

Ocular Blood Flow
NCT05093374 Phase 4
Recruiting

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Exudative Macular Degeneration
NCT05009758
Recruiting

Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps

Asthma
NCT06597916 Phase 2
Recruiting

RSV Vaccination in Immunocompromised Patients.

RSV Infection
NCT06649136 Phase 4
Recruiting

MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients with Active Rheumatoid Arthritis

Rheumatoid Arthritis
NCT06593756
Recruiting

Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - "HemodynamECMOnitoring-VA Study"

ECMO Treatment
NCT06659835
Recruiting

Amino Acid Loss During Continuous Renal Replacement Therapy

Renal Insufficiency
NCT05630469
Recruiting

Prediction of Antidepressant Effects of Electroconvulsive Therapy

Depressive Disorder, Major
NCT05655754 Phase 4
Recruiting

Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT

ECT
NCT07490353 Phase 1
Recruiting

Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects

Depression - Major Depressive Disorder
NCT06178952
Recruiting

Transcranial Pulse Stimulation (TPS) in Post-COVID-19

Post-COVID-19 Syndrome
NCT05716737
Recruiting

Exploring Radiotherapy of Temporomandibular Joint Arthritis

Arthritis of Temporomandibular Joint
NCT05866432 Phase 2
Recruiting

Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Breast Cancer Stage IV
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology